The current status of natural products from marine fungi and their potential as anti-infective agents
- 21 January 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Industrial Microbiology & Biotechnology
- Vol. 33 (5) , 325-337
- https://doi.org/10.1007/s10295-005-0070-3
Abstract
A growing number of marine fungi are the sources of novel and potentially life-saving bioactive secondary metabolites. Here, we have discussed some of these novel antibacterial, antiviral, antiprotozoal compounds isolated from marine-derived fungi and their possible roles in disease eradication. We have also discussed the future commercial exploitation of these compounds for possible drug development using metabolic engineering and post-genomics approaches.Keywords
This publication has 160 references indexed in Scilit:
- Association of Transmission Intensity and Age With Clinical Manifestations and Case Fatality of Severe Plasmodium falciparum MalariaJAMA, 2005
- Small-molecule natural products: new structures, new activitiesCurrent Opinion in Biotechnology, 2004
- Scytalidamides A and B, New Cytotoxic Cyclic Heptapeptides from a Marine Fungus of the Genus ScytalidiumThe Journal of Organic Chemistry, 2003
- γ-Pyrone derivatives, kojic acid methyl ethers from a marine-derived fungusaltenaria spArchives of Pharmacal Research, 2003
- Fungi from marine sponges: diversity, biological activity and secondary metabolitesMycological Research, 2000
- Small bugs, big businessBiotechnology Advances, 2000
- Isolation and Characterization of Bioactive Metabolites from Marine-Derived Filamentous Fungi Collected from Tropical and Sub-Tropical Coral Reefs.CHEMICAL & PHARMACEUTICAL BULLETIN, 2000
- Cyclosporin-A production by Tolypocladium inflatum using solid state fermentationProcess Biochemistry, 1999
- Natural Products in Drug Discovery and DevelopmentJournal of Natural Products, 1997
- Development of high penicillin producing strains for solid state fermentationBiotechnology Advances, 1993